SUSAN SMITH: Open Payments
NPI 1558570002 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$718 in 8 payments from 7 companies in 2025. Trend: 2023 $350 · 2024 $131 · 2025 $718
Food & beverage: $718
| Company | Payments | Amount |
|---|---|---|
| Smith+Nephew, Inc. | 2 | $158 |
| Gilead Sciences, Inc. | 1 | $130 |
| Axsome Therapeutics, Inc. | 1 | $117 |
| Teva Pharmaceuticals USA, Inc. | 1 | $100 |
| ABIOMED | 1 | $96 |
| GENZYME CORPORATION | 1 | $68 |
| Novo Nordisk Inc | 1 | $49 |
Products named: BIOBRANE, Epclusa, Auvelity, FABRAZYME, Wegovy.
Industry payments across FL — which companies pay providers there.
